James A. Conroy is Director at Symmetry Medical Inc. (SMA). They have made 1 open-market trade across 1 company since 2006, most recently 2006-02-22.
CIK 0001298841
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| SMA | 21,600 | $738K |
Shares reported on the most recent Form 4, priced at the 2006-02-23 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| SMA | SELL | 2006-02-22 | 2006-02-23 | $22.17 | $1.3M | -0.2% | +1.1% | +1.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.